High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes

Li Tian1, Shiyin Long, Chuanwei Li

  • 1Laboratory of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.

Insights

Diabetic patients with coronary heart disease (CHD) show abnormal high-density lipoprotein (HDL) subclasses and particle sizes, increasing cardiovascular risk. HDL subclass distribution may aid in stratifying CHD severity and risk, especially with controlled lipid levels.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Lipidology

Background:

  • Coronary heart disease (CHD) prevalence is higher in individuals with diabetes.
  • Investigated high-density lipoprotein (HDL) subclass profiles and particle size alterations in CHD patients with and without diabetes.

Purpose of the Study:

  • To investigate HDL subclass profiles and particle size alterations in CHD patients with and without diabetes.

Main Methods:

  • Quantified plasma HDL subclasses in CHD patients using 1-dimensional gel electrophoresis coupled with immunodetection.

Main Results:

  • CHD patients with diabetes had higher fasting plasma glucose, triglyceride, total cholesterol, LDL-C, and HDL₃ subclasses, but lower HDL-C, HDL(2b+preβ2), and HDL(2a) compared to those without diabetes.
  • Gensini Score was independently predicted by HDL(2a) and HDL(2b+preβ2) subclasses.
  • Despite statin therapy, HDL particle size tended to be smaller in CHD patients.

Conclusions:

  • Abnormal HDL subpopulations distribution and particle size may contribute to CHD risk in diabetic patients.
  • HDL subclass distribution can aid in assessing coronary artery severity and risk stratification, particularly in CHD patients with managed lipid profiles.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...